Origin and segregation of the human germline
-
- Aracely Castillo-Venzor
- Wellcome Trust/Cancer Research UK Gurdon Institute
-
- Christopher A Penfold
- Wellcome Trust/Cancer Research UK Gurdon Institute
-
- Michael D Morgan
- Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
-
- Walfred WC Tang
- Wellcome Trust/Cancer Research UK Gurdon Institute
-
- Toshihiro Kobayashi
- Division of Mammalian Embryology, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
-
- Frederick CK Wong
- Wellcome Trust/Cancer Research UK Gurdon Institute
-
- Sophie Bergmann
- Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK
-
- Erin Slatery
- Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK
-
- Thorsten E Boroviak
- Wellcome - MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK
-
- John C Marioni
- Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK
-
- M Azim Surani
- Wellcome Trust/Cancer Research UK Gurdon Institute
Description
<jats:p>Human germline–soma segregation occurs during weeks 2–3 in gastrulating embryos. Although direct studies are hindered, here, we investigate the dynamics of human primordial germ cell (PGCs) specification using in vitro models with temporally resolved single-cell transcriptomics and in-depth characterisation using in vivo datasets from human and nonhuman primates, including a 3D marmoset reference atlas. We elucidate the molecular signature for the transient gain of competence for germ cell fate during peri-implantation epiblast development. Furthermore, we show that both the PGCs and amnion arise from transcriptionally similar TFAP2A-positive progenitors at the posterior end of the embryo. Notably, genetic loss of function experiments shows that TFAP2A is crucial for initiating the PGC fate without detectably affecting the amnion and is subsequently replaced by TFAP2C as an essential component of the genetic network for PGC fate. Accordingly, amniotic cells continue to emerge from the progenitors in the posterior epiblast, but importantly, this is also a source of nascent PGCs.</jats:p>
Journal
-
- Life Science Alliance
-
Life Science Alliance 6 (8), e202201706-, 2023-05-22
Life Science Alliance, LLC
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1360863107936631424
-
- ISSN
- 25751077
-
- HANDLE
- 2164/20869
-
- PubMed
- 37217306
-
- Data Source
-
- Crossref
- OpenAIRE